BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/6/2023 12:22:17 PM | Browse: 410 | Download: 1449
 |
Received |
|
2022-10-24 07:00 |
|
Peer-Review Started |
|
2022-10-24 07:03 |
|
First Decision by Editorial Office Director |
|
2022-12-12 03:36 |
|
Return for Revision |
|
2022-12-12 03:36 |
|
Revised |
|
2022-12-17 07:07 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-01-16 03:46 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-01-17 06:39 |
|
Articles in Press |
|
2023-01-17 06:39 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-01-28 11:00 |
|
Publish the Manuscript Online |
|
2023-02-06 12:22 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Nitipon Simasingha, Wasu Tanasoontrarat, Torpong Claimon and Supatsri Sethasine |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Navamindradhiraj University Research Fund and the Faculty of Medicine Vajira Hospital, Navamindradhiraj University |
93/2564 |
|
| Corresponding Author |
Supatsri Sethasine, MD, Associate Professor, Chief Doctor, Department of Internal Medicine, Navamindradhiraj University, Vajira Hospital Dusit Thailand, Bangkok 10300, Thailand. supatsri@nmu.ac.th |
| Key Words |
Hepatocellular carcinoma; Post-embolization syndrome; Transarterial chemoembolization; Liver decompensation |
| Core Tip |
Conventional transarterial chemoembolization (TACE) is the current standard treatment for intermediate-stage hepatocellular carcinoma (HCC). A combination of N-acetylcysteine and dexamethasone ameliorated the occurrence of post-embolization syndrome event after TACE in patients with intermediate-stage HCC. A dynamic change in Albumin-Bilirubin score of more than 0.5 point was found to be a risk factor for post-TACE liver decompensation. |
| Publish Date |
2023-02-06 12:22 |
| Citation |
Simasingha N, Tanasoontrarat W, Claimon T, Sethasine S. Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma. World J Gastroenterol 2023; 29(5): 890-903 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i5/890.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i5.890 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
